Vespa Investment

Vespa Capital is a leading UK-based private equity investor focused on the lower mid-market. The firm partners with founders and management teams of high-growth businesses across tech-enabled services, software, life sciences & healthcare sectors. It has over £300 million in assets under management and supports recapitalisations and management buyouts for businesses valued between £10m–£70m. Its portfolio includes several notable healthcare/life science service providers such as FibroFind (pre-clinical CRO), Chase Search and Selection (pharma/biotech recruitment), Cognite (healthcare strategy agency), Random42 (digital pharma communications), among others. Vespa Capital provides growth capital and strategic support but does not itself conduct drug discovery or development.